Spanish Red Biotech Pipeline

PROMEGA BIOTECH IBÉRICA

Microsatellite Instability Analysis CE-IVD

Type: Biomarkers / Diagnostic
Therapeutic area: Cancer
Indication: Characterize MSI Status by a Fluorescent Multiplex PCR-based method with CE/IVD label
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Global